Barely Significant
← all phrases

“nearly significant”

3,288 sentences · 3,288 papers · 3,853 search hits before verification · confirmed specimen

Sighted at

p=0.0579p=0.06

Listed by Hankins, posted since · Hankins (2013) · Otte et al. (2022)

In the literature

The nearly significant interaction between SCR Time Window and Performance indicated that the SCR amplitude difference between correct‐fast and correct‐slow response was not significant in the early time window, t (25) = 0.43, p = .674, but significant in the late time window, t (25) = 3.41, p = .002, d = 0.67. 3.3 Response‐locked ERP Errors evoked a significantly larger response‐related negativity than correct‐fast and correct‐slow responses, t (27) = 2.69, p = .012, d = 0.51, and t (27) = 3.99, p < .001, d = 0.75, respectively.
With multivariable adjustment, change in weight was significantly associated with changes in one of the four histologic features (steatosis), AST with two features (inflammation and fibrosis) and nearly significant for another one (steatosis), HbA1c with two features (ballooning and inflammation) and nearly significant for another one (steatosis), GGT with one (steatosis), and CK‐18[M65] with one (ballooning) and nearly significant for another one (inflammation).
With regard to the treatment length necessary to observe significant changes in basophil activation, according to previous reports, we found no significant decrease in basophil activation in the analysis performed 6 23 and 12 months after the initiation of VIT; 28 however, it was significantly observed 3 months after starting the maintenance dose, and nearly significant in the first month.
A post hoc analysis from the ORAL Surveillance study reported a nearly significant higher MACE risk with tofacitinib 5 mg BID (8.3%; 17/204) and 10 mg BID (7.7%; 17/222) compared to TNF inhibitors in patients with rheumatoid arthritis and a history of atherosclerotic cardiovascular disease (HR 1.98, 95% CI 0.95–4.14, p = 0.196); the highest risk was associated with age > 50 years and at least one additional cardiovascular (CV) risk [ 46 ].